The Acetylcholinesterase Inhibitor Rivastigmine Does Not Alter Total Choices for Methamphetamine, but May Reduce Positive Subjective Effects, in a Laboratory Model of Intravenous Self-Administration in Human Volunteers
Pharmacology Biochemistry and Behavior - United States
doi 10.1016/j.pbb.2007.12.010
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2008
Authors
Publisher
Elsevier BV